Central regulation of breast cancer growth and metastasis

Abstract

Cancer is a systemic disease. In order to fully understand it, we must take a holistic view on how cancer interacts with its host. The brain monitors and responds to natural and aberrant signals arriving from the periphery, particularly those of metabolic or immune origin. As has been well described, a hallmark of cancer is marked disruption of metabolic and inflammatory processes. Depending on the salience and timing of these inputs, the brain responds via neural and humoral routes to alter whole-body physiology. These responses have consequences for tumor growth and metastasis, directly influencing patient quality of life and subsequent mortality. Additionally, environmental inputs such as light, diet, and stress, can promote inappropriate neural activity that benefits cancer. Here, I discuss evidence for brain-tumor interactions, with special emphasis on subcortical neuromodulator neural populations, and potential ways of harnessing this cross-talk as a novel approach for cancer treatment.

Keywords

Breast cancer / hypothalamus / immunometabolism / sympathetic nervous system / neuromodulators

References

[1] Bachmann J,Krakowski-Roosen H,Friess H.Cachexia worsens prognosis in patients with resectable pancreatic cancer..J Gastrointest Surg2008;12:1193

[2] Cash E,Chagpar AB,Rebholz WN.Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery..Brain Behav Immun2015;48:102-14

[3] Palesh O,Zeitzer JM,Neri E.Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer..Sleep2014;37:837-42 PMCID:PMC3985107

[4] Sephton SE,Kraemer HC.Diurnal cortisol rhythm as a predictor of breast cancer survival..J Natl Cancer Inst2000;92:994-1000

[5] Zhi J,Kuk D,Sorg R.Association of baseline body mass index (BMI) with overall survival (OS) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) treated with nivolumab (N) and pembrolizumab (P)..J Clin Oncol2018;36:6553-3

[6] Borniger JC,Surbhi,Zhang N.A role for hypocretin/orexin in metabolic and sleep abnormalities in a mouse model of non-metastatic breast cancer..Cell Metab2018;28:118-29.e5 PMCID:PMC6031468

[7] Colegio OR,Szabo AL,Rhebergen AM.Functional polarization of tumour-associated macrophages by tumour-derived lactic acid..Nature2014;513:559-63 PMCID:PMC4301845

[8] Grivennikov SI,Karin M.Immunity, inflammation, and cancer..Cell2010;140:883-99 PMCID:PMC2866629

[9] Hanahan D.Hallmarks of cancer: the next generation..Cell2011;144:646-74

[10] Masri S,Kinouchi K,Cervantes M.Lung adenocarcinoma distally rewires hepatic circadian homeostasis..Cell2016;165:896-909 PMCID:PMC5373476

[11] Antoni MH,Cole SW,Sephton SE.The influence of bio-behavioural factors on tumour biology: pathways and mechanisms..Nat Rev Cancer2006;6:240-8 PMCID:PMC3146042

[12] Thaker PH,Kamat AA,Takahashi R.Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma..Nat Med2006;12:939-44

[13] Hakim F,Zhang SX,Yolcu ES.Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling..Cancer Res2014;74:1329-37 PMCID:PMC4247537

[14] Evans JMM,Emslie-Smith AM,Morris AD.Metformin and reduced risk of cancer in diabetic patients..BMJ2005;330:1304-5 PMCID:PMC558205

[15] Hirsch HA,Tsichlis PN.Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission..Cancer Res2009;69:7507-11 PMCID:PMC2756324

[16] Dean GE,Wang YJ,Dickerson SS.Sleep, mood, and quality of life in patients receiving treatment for lung cancer..Oncol Nurs Forum2013;40:441-51 PMCID:PMC4080434

[17] Fortner BV,Wang SC,Durrence HH.Sleep and quality of life in breast cancer patients..J Pain Symptom Manage2002;24:471-80

[18] Zeitlhofer J,Tribl G,Bolitschek J.Sleep and quality of life in the Austrian population..Acta Neurol Scand2000;102:249-57

[19] Irwin ML,Baumgartner RN,Bernstein L.Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors..J Clin Oncol2005;23:774-82 PMCID:PMC3000612

[20] Davidson JR,Brundage MD.Sleep disturbance in cancer patients..Soc Sci Med2002;54:1309-21

[21] Sephton SE,Dedert EA,Rebholz WN.Diurnal cortisol rhythm as a predictor of lung cancer survival..Brain Behav Immun2013;30:S163-70

[22] Stevens RG,Blask DE,Motta ME.Breast cancer and circadian disruption from electric lighting in the modern world..CA Cancer J Clin2014;64:207-18 PMCID:PMC4038658

[23] Borniger JC,Zhang N,DeVries AC.Cytotoxic chemotherapy increases sleep and sleep fragmentation in non-tumor-bearing mice..Brain Behav Immun2015;47:218-27

[24] Bonnavion P,Fujita A,Jackson AC.Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour..J Physiol2016;594:6443-62 PMCID:PMC5108896

[25] Williams G,Cai XJ,King PJ.The hypothalamus and the control of energy homeostasis: different circuits, different purposes..Physiol Behav2001;74:683-701

[26] Nevárez N.Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation..F1000Res2018;7:1421 PMCID:PMC6127742

[27] Tyree SM,de Lecea L.Hypocretin as a Hub for arousal and motivation..Front Neurol2018;9:413 PMCID:PMC5997825

[28] de Lecea L,Peyron C,Foye PE.The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity..Proc Natl Acad Sci1998;95:322-7 PMCID:PMC18213

[29] Sakurai T,Ishii M,Chemelli RM.Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior..Cell1998;92:573-85

[30] Chemelli RM,Sinton CM,Scammell T.Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation..Cell1999;98:437-51

[31] Crocker A,Papadopoulou M,Faraco J.Concomitant loss of dynorphin, NARP, and orexin in narcolepsy..Neurology.2005;65:1184-8 PMCID:PMC2254145

[32] Hara J,Nambu T,Chemelli RM.Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity..Neuron2001;30:345-54

[33] Nishino S,Overeem S,Mignot E.Hypocretin (orexin) deficiency in human narcolepsy..Lancet2000;355:39-40

[34] Geerling JC,Loewy AD.Orexin neurons project to diverse sympathetic outflow systems..Neuroscience2003;122:541-50

[35] Yi CX,Ackermans MT,Buijs RM.A major role for perifornical orexin neurons in the control of glucose metabolism in rats..Diabetes2009;58:1998-2005 PMCID:PMC2731521

[36] Bonnavion P,Carter ME.Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses..Nat Commun2015;6:6266 PMCID:PMC4335349

[37] Goforth PB,Patterson CM,Myers MG.Leptin acts via lateral hypothalamic area neurotensin neurons to inhibit orexin neurons by multiple GABA-independent mechanisms..J Neurosci2014;34:11405-15 PMCID:PMC4138347

[38] Håkansson M,Sutcliffe JG,Meister B.Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus..J Neuroendocrinol1999;11:653-63

[39] Garofalo C,Cascio S,Kanczuga-Koda L.Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli..Clin Cancer Res2006;12:1447-53

[40] Ishikawa M,Nagawa H.Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer..Clin Cancer Res2004;10:4325-31

[41] Nakazato M,Date Y,Matsuo H.A role for ghrelin in the central regulation of feeding..Nature2001;409:194-8

[42] Olszewski PK,Grace MK,Kotz CM.Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus..Peptides2003;24:597-602

[43] Tschöp M,Heiman ML.Ghrelin induces adiposity in rodents..Nature2000;407:908-13

[44] García-García F,Santiago-García J.Ghrelin and its interactions with growth hormone, leptin and orexins: Implications for the sleep-wake cycle and metabolism..Sleep Med Rev2014;18:89-97

[45] Toshinai K,Murakami N,Mondal MS.Ghrelin-induced food intake is mediated via the orexin pathway..Endocrinology2003;144:1506-12

[46] Au CC,Brown KA.Ghrelin and breast cancer: emerging roles in obesity, estrogen regulation, and cancer..Front Oncol2017;6:265 PMCID:PMC5220482

[47] Gahete MD,Hergueta-Redondo M,Kineman RD.A novel human ghrelin variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance..PLoS One2011;6:e23302 PMCID:PMC3150424

[48] Shimizu Y,Isobe T,Okumura H.Increased plasma ghrelin level in lung cancer cachexia..Clin Cancer Res2003;9:774-8

[49] McAlpine CS,Rattik S,Vassalli A.Sleep modulates haematopoiesis and protects against atherosclerosis..Nature2019;566:383-7

[50] Akhtar RA,Maywood ES,King VM.Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus..Curr Biol2002;12:540-50

[51] O’Neill JS,Chesham JE,Hastings MH.cAMP-dependent signaling as a core component of the mammalian circadian pacemaker..Science2008;320:949-53 PMCID:PMC2735813

[52] Partch CL,Takahashi JS.Molecular architecture of the mammalian circadian clock..Trends Cell Biol2014;24:90-9 PMCID:PMC3946763

[53] Stephan FK.Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions..Proc Natl Acad Sci U S A1972;69:1583-6 PMCID:PMC426753

[54] Baver SB,Sollars PJ.Two types of melanopsin retinal ganglion cell differentially innervate the hypothalamic suprachiasmatic nucleus and the olivary pretectal nucleus..Eur J Neurosci2008;27:1763-70

[55] Hattar S,Takao M,Yau KW.Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity..Science2002;295:1065-70 PMCID:PMC2885915

[56] Borniger JC,Surbhi.Reciprocal regulation of circadian rhythms and immune function..Curr Sleep Med Rep2017;3:93-103

[57] Scheiermann C,Frenette PS.Circadian control of the immune system..Nat Rev Immunol2013;13:190-8 PMCID:PMC4090048

[58] Cadenas C,Edlund K,Hellwig B.Loss of circadian clock gene expression is associated with tumor progression in breast cancer..Cell Cycle Georget Tex2014;13:3282-91 PMCID:PMC4613905

[59] Stevens RG.Circadian disruption and breast cancer: from melatonin to clock genes..Epidemiol Camb Mass2005;16:254-8

[60] Van Dycke KCG,van Oostrom CTM,Pennings JLA.Chronically alternating light cycles increase breast cancer risk in mice..Curr Biol2015;25:1932-7

[61] Papagiannakopoulos T,Davidson SM,Subbaraj L.Circadian rhythm disruption promotes lung tumorigenesis..Cell Metab2016;24:324-31 PMCID:PMC5367626

[62] Davidson SM,Olenchock BA,Keibler MA.Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer..Cell Metab2016;23:517-28 PMCID:PMC4785096

[63] He B,Park N,Guillory B.The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome..Cell Metab2016;23:610-21 PMCID:PMC4832569

[64] Chen J,Huang H,Rollyson WD.The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway..Int J Oncol2015;46:2629-38 PMCID:PMC4441297

[65] Li N,Jiang G,Yu D.Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway..Front Biosci Landmark Ed2019;24:303-12

[66] Sp N,Joung YH,Kim WS.Nobiletin inhibits angiogenesis by regulating Src/FAK/STAT3-mediated signaling through PXN in ER+ breast cancer cells..Int J Mol Sci2017;18:E935 PMCID:PMC5454848

[67] Bedrosian TA,Walton JC,Weil ZM.Evidence for feedback control of pineal melatonin secretion..Neurosci Lett2013;542:123-5

[68] Borniger JC.Photoperiodic regulation of behavior: peromyscus as a model system..Semin Cell Dev Biol2017;61:82-91

[69] Hardeland R.Non-vertebrate melatonin..J Pineal Res2003;34:233-41

[70] Tan DX,Manchester LC,Korkmaz A.The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness..Biol Rev2010;85:607-23

[71] Teclemariam-Mesbah R,Postema F,Buijs RM.Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway..J Comp Neurol1999;406:171-82

[72] Carrillo-Vico A,Abreu P,García-Mauriño S.Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance..FASEB J2004;18:537-9

[73] Carrillo-Vico A,Álvarez-Sánchez N,Guerrero JM.Melatonin: buffering the immune system..Int J Mol Sci2013;14:8638-83 PMCID:PMC3645767

[74] Hardeland R,Srinivasan V,Brown GM.Melatonin--a pleiotropic, orchestrating regulator molecule..Prog Neurobiol2011;93:350-84

[75] Erren TC,Morfeld P,Reiter RJ.Shift work and cancer..Dtsch Ärztebl Int2010;107:657-62 PMCID:PMC2954516

[76] Davis S,Stevens RG.Night shift work, light at night, and risk of breast cancer..J Natl Cancer Inst2001;93:1557-62

[77] James P,Hart JE,Tamimi RM.Outdoor light at night and breast cancer incidence in the Nurses’ Health Study II..Environ Health Perspect2017;125:087010 PMCID:PMC5783660

[78] Johns LE,Schoemaker MJ,Ashworth A.Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the generations study..Br J Cancer2018;118:600-6 PMCID:PMC5830585

[79] Blask DE,Dauchy RT,Davidson LK.Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats..Cancer Res2005;65:11174-84

[80] Hill SM,Dauchy RT,Brimer S.Melatonin: an inhibitor of breast cancer..Endocr Relat Cancer2015;22:R183-204 PMCID:PMC4457700

[81] Mao L,Blask DE,Slakey LM.Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma..J Pineal Res2016;60:167-77

[82] Reiter RJ,Tan DX,Qin L.Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis..Int J Mol Sci2017;18:E843 PMCID:PMC5412427

[83] Xiang S,Hauch A,Yuan L.Doxorubicin resistance in breast cancer is driven by light at night induced disruption of the circadian melatonin signal..J Pineal Res2015;59:60-9 PMCID:PMC4490975

[84] Teunis MA,Voest E,Ellenbroek BA.Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system..FASEB J2002;16:1465-7

[85] Peters MAM,Kema IP,de Vries EGE.Dopamine and serotonin regulate tumor behavior by affecting angiogenesis..Drug Resist Updat2014;17:96-104

[86] Ben-Shaanan TL,Dubovik T,Korin B.Activation of the reward system boosts innate and adaptive immunity..Nat Med2016;22:940-4

[87] Ben-Shaanan TL,Azulay-Debby H,Boshnak N.Modulation of anti-tumor immunity by the brain’s reward system..Nat Commun2018;9:2723 PMCID:PMC6045610

[88] Barnes PJ.Anti-inflammatory actions of glucocorticoids: molecular mechanisms..Clin Sci Lond Engl. 1979;1998;94:557-72

[89] Sklar LS.Stress and coping factors influence tumor growth..Science1979;205:513-5

[90] Sklar LS.Social stress influences tumor growth..Psychosom Med1980;42:347-65

[91] Flint TR,Connell CM,Denton AE.Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity..Cell Metab2016;24:672-84 PMCID:PMC5106372

[92] Oster H,Kiessling S,Abraham D.The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock..Cell Metab2006;4:163-73

[93] Sood AK,Kamat AA,Han L.Stress hormone-mediated invasion of ovarian cancer cells..Clin Cancer Res2006;12:369-75 PMCID:PMC3141061

[94] Shaashua L,Haldar R,Zmora O.Perioperative COX-2 and β-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial..Clin Cancer Res2017;23:4651-61 PMCID:PMC5559335

[95] Heiden MGV,Thompson CB.Understanding the warburg effect: the metabolic requirements of cell proliferation..Science2009;324:1029-33 PMCID:PMC2849637

[96] Warburg O.On the origin of cancer cells..Science1956;123:309-14

[97] Warburg O,Negelein E.The metabolism of tumors in the body..J Gen Physiol1927;8:519-30 PMCID:PMC2140820

[98] Bharadwaj S,Mariappan R,Meng Y.Serum lactate as a potential biomarker of non-glial brain tumors..J Clin Neurosci2015;Oct22:1625-7

[99] Ezeoke CC.Pathophysiology of anorexia in the cancer cachexia syndrome..J Cachexia Sarcopenia Muscle2015;6:287-302 PMCID:PMC4670736

[100] Mariappan R,Vertanian A,Cynthia S.Serum lactate as a potential biomarker of malignancy in primary adult brain tumours..J Clin Neurosci2015;22:144-8

[101] Zhou L,Shao Z,Xie H.Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients with extensive-disease small cell lung cancer: a retrospective cohort study..J Thorac Dis2018;10:1043-9 PMCID:PMC5864672

[102] Cortes-Campos C,Carril C,Boric K.MCT2 expression and lactate influx in anorexigenic and orexigenic neurons of the arcuate nucleus..PLoS One2013;8:e62532 PMCID:PMC3637215

[103] Cha SH.Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway..Biochem Biophys Res Commun2009;386:212-6

[104] Chance WT,Friend LA.Elevated blood lactate is not a primary cause of anorexia in tumor-bearing rats..Nutr Cancer2004;48:174-81

[105] Campos CA,Schwartz MW.Parabrachial CGRP neurons control meal termination..Cell Metab2016;23:811-20 PMCID:PMC4867080

[106] Carter ME,Zweifel LS.Genetic identification of a neural circuit that suppresses appetite..Nature2013;503:111-4 PMCID:PMC3878302

[107] Roman CW,Palmiter RD.Genetically and functionally defined NTS to PBN brain circuits mediating anorexia..Nat Commun2016;7:11905 PMCID:PMC4912612

[108] Han S,Soden ME,Palmiter RD.Elucidating an affective pain circuit that creates a threat memory..Cell2015;162:363-74 PMCID:PMC4512641

[109] Campos CA,Han S,Palmiter RD.Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus..Nat Neurosci2017;20:934-42 PMCID:PMC5538581

[110] De Vadder F,Goncalves D,Zitoun C.Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits..Cell2014;156:84-96

[111] Routy B,Derosa L,Alou MT.Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors..Science2018;359:91-7

[112] Lakritz JR,Mirabal S,Levkovich T.Gut bacteria require neutrophils to promote mammary tumorigenesis..Oncotarget2015;6:9387-96 PMCID:PMC4496224

[113] Levi F.Circadian rhythms: mechanisms and therapeutic implications..Annu Rev Pharmacol Toxicol2007;47:593-628

[114] Mormont MC.Cancer chronotherapy: principles, applications, and perspectives..Cancer2003;97:155-69

[115] Borniger JC,Gaudier-Diaz MM,Zhang N.Time-of-day dictates transcriptional inflammatory responses to cytotoxic chemotherapy..Sci Rep2017;7:41220 PMCID:PMC5259749

[116] Dycke KCGV,Wackers PFK,Rodenburg W.A day and night difference in the response of the hepatic transcriptome to cyclophosphamide treatment..Arch Toxicol2015;89:221-31

[117] Lipp A,Trottenberg T,Arnold G.Sympathetic activation due to deep brain stimulation in the region of the STN..Neurology2005;65:774-5

[118] Parsons TD,Braaten AJ,Tröster AI.Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis..Lancet Neurol2006;5:578-88

[119] Bower JE,Stanton AL,Winston D.Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial..Cancer2015;121:1231-40 PMCID:PMC4393338

[120] Palesh OG,Mustian KM,Savard J.Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: university of rochester cancer center-community clinical oncology program..J Clin Oncol2010;28:292-8 PMCID:PMC2815717

[121] Ancoli-Israel S,Marler MR,Jones V.Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer..Support Care Cancer2006;14:201-9 PMCID:PMC1599708

[122] Moore M,Innominato PF,Kesler S.Sleep, circadian disruption and neurocognition in breast cancer (BC) patients undergoing chemotherapy..J Clin Oncol2016;34:10072

[123] Zhu Y,Zhang Y,Zheng T.Period3 structural variation: a circadian biomarker associated with breast cancer in young women..Cancer Epidemiol Prev Biomark2005;14:268-70

[124] Dedert E,Chagpar A,Segerstrom SC.Stress, coping, and circadian disruption among women awaiting breast cancer surgery..Ann Behav Med2012;44:10-20

[125] Pereira J,Bruera E.The frequency and clinical course of cognitive impairment in patients with terminal cancer..Cancer1997;79:835-42

[126] Hutchinson AD,Kichenadasse G,Wilson C.Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review..Cancer Treat Rev2012;38:926-34

[127] Von Ah D,Carpenter JS.Impact of perceived cognitive impairment in breast cancer survivors..Eur J Oncol Nurs2013;17:236-41

[128] Jenkins V,Deutsch G,Morris R.A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer..Br J Cancer2006;94:828-34 PMCID:PMC3216421

[129] Villarreal-Garza C,Lara-Medina F,Rivera D.Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients..J Diabetes Res2012;2012:e732027 PMCID:PMC3419428

[130] Larsson SC,Wolk A.Diabetes mellitus and risk of breast cancer: a meta-analysis..Int J Cancer2007;121:856-62

[131] Schoemaker MJ,Wright LB,Jones ME.Association of body mass index and age with subsequent breast cancer risk in premenopausal women..JAMA Oncol2018;4:e181771 PMCID:PMC6248078

[132] Muti P,Grant BJB,Micheli A.Fasting glucose is a risk factor for breast cancer: a prospective study..Cancer epidemiol prev biomark2002;11:1361-8

[133] Xuan C,Chung A,Chung M.Microbial dysbiosis is associated with human breast cancer..PLoS One2014;9:e83744 PMCID:PMC3885448

[134] Goedert JJ,Hua X,Yu G.Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study..J Natl Cancer Inst2015;107:djv147 PMCID:PMC4554191

[135] Luu TH,Bard JM,Nazih H.Intestinal proportion of blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer..Nutr Cancer2017;69:267-75

[136] Minelli EB,Vesentini S,Nardo G.Intestinal microflora as an alternative metabolic source of estrogens in women with uterine leiomyoma and breast cancer..Ann N Y Acad Sci1990;595:473-9

[137] Pierce BL,Bernstein L,Neuhouser ML.Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients..J Clin Oncol2009;27:3437-44 PMCID:PMC2717751

[138] Murri AMA,Canney PA,Wilson C.Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer..Br J Cancer2006;94:227-30 PMCID:PMC2361117

[139] McMillan DC,Sattar N,Johnstone J.Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer..Nutr Cancer2001;41:64-9

[140] Iyengar NM,Gucalp A,Howe LR.Systemic correlates of white adipose tissue inflammation in early-stage breast cancer..Clin Cancer Res2016;22:2283-9 PMCID:PMC4854755

[141] Pyter LM,Galang JA,Prendergast BJ.Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation..Proc Natl Acad Sci U S A2009;106:9069-74 PMCID:PMC2689998

[142] Norden DM,Bicer S,Reiser PJ.Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue..Physiol Behav2015;140:230-5 PMCID:PMC4298482

[143] Norden DM,Clark Y,Henry CJ.Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function..Brain Behav Immun.2015;43:76-85 PMCID:PMC4258420

[144] Grossberg AJ,Leinninger GM,Braun TP.Inflammation-induced lethargy is mediated by suppression of orexin neuron activity..J Neurosci2011;31:11376-86 PMCID:PMC3155688

[145] Huan H,Chen X,Wu L.Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells..Brain Behav Immun2017;59:118-34

[146] Basu S,Chakroborty D,Mitra RB.Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis..Cancer Res2004;64:5551-5

[147] Filipski E,Li X,Mormont MC.Disruption of circadian coordination accelerates malignant growth in mice..Pathol Biol (Paris)2003;51:216-9

[148] Khalyfa A,Gileles-Hillel A,Trzepizur W.Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation..Oncotarget2016;7:54676-90 PMCID:PMC5342372